The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.
Open accessAbstract
The observation that type III erythrocytes of paroxysmal nocturnal hemoglobinuria (PNH) are susceptible to hemolysis initiated by activated cobra venom factor complexes (CoFBb), whereas normal erythrocytes are resistant, implies that the PNH III cells are deficient in a membrane constituent that regulates this process. To isolate the inhibitory factor from normal erythrocytes, membrane proteins were first extracted with butanol and then subjected to sequential anion exchange, hydroxylapatite, and hydrophobic chromatography. Analysis by SDS-PAGE and silver stain of the inhibitory fractions showed a single band corresponding to a protein with an apparent Mr of 18 kD. PNH erythrocytes were incubated with incremental concentrations of the radiolabeled protein and then washed. In a dose-dependent fashion, the protein incorporated into the cell membrane and inhibited CoFBb-initiated lysis. This protein inhibitor functioned by restricting the assembly of the membrane attack complex at the level of C7 and C8 incorporation. By using a monospecific antibody to block the function of the inhibitor, it was shown that normal erythrocytes are rendered susceptible to CoFBb-initiated hemolysis. Analysis by Western blot of membrane proteins revealed that PNH III erythrocytes are deficient in the 18-kD protein. By virtue of its molecular weight and inhibitory activity, the 18-kD protein appears to be discrete from other previously described erythrocyte membrane proteins that regulate complement. These studies also indicate that the susceptibility of PNH III erythrocytes to reactive lysis is causally related to a deficiency of the 18-kD membrane inhibitor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 20,298
Blake, M. S., Johnston, K. H., Russell-Jones, G. J., & Gotschlich, E. C. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90320-8 · Cited by 2,136
Structural and Functional Roles of Glycosyl-Phosphatidylinositol in Membranes
Low, M. G., & Saltiel, A. R. (1988) · Science · doi:10.1126/science.3276003 · Cited by 952
Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.547 · Cited by 645
Medof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561
Nicholson-Weller, A., March, J. P., Rosenfeld, S. I., & Austen, K. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.16.5066 · Cited by 428
Kinoshita, T., Medof, M. E., Silber, R., & Nussenzweig, V (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.1.75 · Cited by 400
Selvaraj, P., Rosse, W. F., Silber, R., & Springer, T. A. (1988) · Nature · doi:10.1038/333565a0 · Cited by 379
Davitz, M. A., Low, M. G., & Nussenzweig, V (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1150 · Cited by 353
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5430 · Cited by 317
Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid
Medof, M. E., Walter, E. I., Roberts, W. L., Haas, R., & Rosenberry, T. L. (1986) · Biochemistry · doi:10.1021/bi00370a003 · Cited by 286
Nicholson-Weller, A., Spicer, D. B., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121704 · Cited by 152
Nicholson-Weller, A., March, J., Rosen, C., Spicer, D. B., & Austen, K. F. (1985) · Blood · doi:10.1182/blood.v65.5.1237.1237 · Cited by 146
Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
Hänsch, G. M., Hammer, C. H., Vanguri, P., & Shin, M. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5118 · Cited by 127
Hänsch, G. M., Schönermark, S., & Roelcke, D. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113065 · Cited by 112
Medof, M. E., Gottlieb, A., Kinoshita, T., Hall, S., Silber, R., Nussenzweig, V., & Rosse, W. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113043 · Cited by 85
Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
Stewart, J. L., Kolb, W. P., & Sodetz, J. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.6.1960 · Cited by 44
Parker, C. J., Soldato, C. M., & Telen, M. J. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111472 · Cited by 34
Self-citation
Cited by
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Young, N. S., Schubert, J., Brodsky, R. A., Socié, G., Muus, P., Röth, A., Szer, J., Elebute, M. O., Nakamura, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061648 · Cited by 1,303
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Natural History of Paroxysmal Nocturnal Hemoglobinuria
Hillmen, P., Lewis, S. M., Bessler, M., Luzzatto, L., & Dacie, J. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331904 · Cited by 907
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778
Metadata
- Authors
- Holguin, M. H., Fredrick, L. R., Bernshaw, N. J., Wilcox, L. A., & Parker, C. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 7-17
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2127290864
- Cited by
- 403
- References
- 18
- FWCI
- 11.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.